Protagonist Therapeutics founder Associate Professor Mark Smythe

Two companies founded on University of Queensland research have won acclaim at the National AusBiotech Conference in Melbourne.

31 October 2016
Dr Kate Schroder, Deputy Director, IMB Centre for Inflammation Research

Inflazome Ltd, a company founded on research from The University of Queensland (UQ) and Trinity College Dublin, has closed a Series A financing round of up to €15 million (A$22 million).

12 September 2016